Neo 2 transcatheter heart valve system: Direct towards a minimalistic procedure

Transcatheter aortic valve replacement (TAVR) has expanded dramatically over the last two decades fueled by the results of multiple clinical trials demonstrating that TAVR is at least non-inferior to surgery for the treatment of patients with symptomatic severe aortic stenosis across the whole range of surgical risks [1].
Source: International Journal of Cardiology - Category: Cardiology Authors: Tags: Editorial Source Type: research